Search
forResearch 10 of 1000+
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Targeting integrin pathways: mechanisms and advances in therapy
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Dermatologic Reactions to Targeted Therapy
- Alopecia - the search for novel agents continues
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →